These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11668121)

  • 1. Treatment of sepsis with activated protein C.
    Hinds CJ
    BMJ; 2001 Oct; 323(7318):881-2. PubMed ID: 11668121
    [No Abstract]   [Full Text] [Related]  

  • 2. [Activated protein C in sepsis].
    Brandtzaeg P
    Tidsskr Nor Laegeforen; 2004 Mar; 124(6):766. PubMed ID: 15039802
    [No Abstract]   [Full Text] [Related]  

  • 3. Activated protein C for sepsis.
    Toussaint S; Gerlach H
    N Engl J Med; 2009 Dec; 361(27):2646-52. PubMed ID: 20042756
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe sepsis, coagulation, and fibrinolysis: dead end or one way?
    Fourrier F
    Crit Care Med; 2012 Sep; 40(9):2704-8. PubMed ID: 22732284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An opinion too far--the campaign against the Surviving Sepsis Campaign.
    Barie PS
    Surg Infect (Larchmt); 2006 Dec; 7(6):485-8. PubMed ID: 17233565
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of anticoagulants in patients with sepsis.
    Langer M; Riccardi F; Piovella F; Klersy C
    JAMA; 2002 Jan 23-30; 287(4):448-9. PubMed ID: 11798358
    [No Abstract]   [Full Text] [Related]  

  • 7. Protein C may be sepsis solution.
    Garber K
    Nat Biotechnol; 2000 Sep; 18(9):917-8. PubMed ID: 10973198
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of activated protein C in the pathophysiology of severe sepsis.
    Dettenmeier P; Swindell B; Stroud M; Arkins N; Howard A
    Am J Crit Care; 2003 Nov; 12(6):518-24; quiz 525-6. PubMed ID: 14619357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Human recombinant activated protein C in patients with severe sepsis and septic shock].
    Segal E
    Harefuah; 2002 Feb; 141(2):130-1. PubMed ID: 11905079
    [No Abstract]   [Full Text] [Related]  

  • 10. Risks and benefits of activated protein C treatment for severe sepsis.
    Warren HS; Suffredini AF; Eichacker PQ; Munford RS
    N Engl J Med; 2002 Sep; 347(13):1027-30. PubMed ID: 12324562
    [No Abstract]   [Full Text] [Related]  

  • 11. Continuing challenges of sepsis research.
    Crowther MA; Marshall JC
    JAMA; 2001 Oct; 286(15):1894-6. PubMed ID: 11597294
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessing the use of activated protein C in the treatment of severe sepsis.
    Siegel JP
    N Engl J Med; 2002 Sep; 347(13):1030-4. PubMed ID: 12324563
    [No Abstract]   [Full Text] [Related]  

  • 13. Drotrecogin alpha and anticoagulants in septic patients after cardiac surgery.
    Pappalardo F; Cristallo E; Franco A; Antonioli G; Zangrillo A
    Eur J Anaesthesiol; 2007 Mar; 24(3):294-5. PubMed ID: 17054810
    [No Abstract]   [Full Text] [Related]  

  • 14. Systemic and organ dysfunction response during infusion of recombinant human activated protein C (rhAPC) in severe sepsis and septic shock.
    Gullo A; Iscra F; Di Capua G; Berlot G; Lucangelo U; Peratoner A; Fasiolo S; Viviani M; Consales C; Zicari A
    Minerva Anestesiol; 2005 Dec; 71(12):785-801. PubMed ID: 16288186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using high quality clinical databases to complement the results of randomised controlled trials: the case of recombinant human activated protein C.
    Padkin A; Rowan K; Black N
    BMJ; 2001 Oct; 323(7318):923-6. PubMed ID: 11668142
    [No Abstract]   [Full Text] [Related]  

  • 16. [Can we still afford progress in intensive care medicine? Re: the article from DMW 1-2/2004].
    Rustige J
    Dtsch Med Wochenschr; 2004 Jul; 129(31-32):1698; author reply 1699-70. PubMed ID: 15273923
    [No Abstract]   [Full Text] [Related]  

  • 17. Recombinant human activated protein C for the treatment of severe sepsis: is there a role in pediatrics?
    Giroir BP
    Curr Opin Pediatr; 2003 Feb; 15(1):92-6. PubMed ID: 12544278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reassessing recombinant human activated protein C for sepsis: time for a new randomized controlled trial.
    Eichacker PQ; Danner RL; Suffredini AF; Cui X; Natanson C
    Crit Care Med; 2005 Oct; 33(10):2426-8. PubMed ID: 16215410
    [No Abstract]   [Full Text] [Related]  

  • 19. We've made progress in the treatment of sepsis, so do we still need sepsis trials?
    Vincent JL
    Minerva Anestesiol; 2013 Jan; 79(1):1-2. PubMed ID: 23299044
    [No Abstract]   [Full Text] [Related]  

  • 20. Coagulation and sepsis: a winding road ahead.
    Levi M
    Crit Care Med; 2012 Sep; 40(9):2733-4. PubMed ID: 22903108
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.